The elevated expression levels of HDAC-1, −2, −4 and −6 in pancreatic adenocarcinoma may reinforce the therapeutic utility of HDAC targeting in pancreatic cancer chemoprevention, taking into consideration the anti-cancer properties of HDACIs in cell proliferation, differentiation and apoptosis [6–13]. The gene discussed is HDAC9; the disease is cancer.